Tirzepatide Significantly Reduces HbA1c, Body Weight in Type 1 Diabetes
A new proof-of-concept observation study reports the dual GLP-1/GIP agonist's positive efficacy and safety for adults with T1D.
Source: hcplive.com
Stay updated with breaking news from Concept Observational. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new proof-of-concept observation study reports the dual GLP-1/GIP agonist's positive efficacy and safety for adults with T1D.